Stimolazione cerebrale e malattia di Parkinson

Autor: Guehl, D., Burbaud, P., Courtin, E., Cuny, E., Damon-Perrière, N.

Publikováno v: In EMC – Neurologia May 2023 23(2):1-16

Clinical Neurology in Practice: The Tongue (part 2).

Autor: Mathis S; Department of Neurology, Muscle-Nerve Unit, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; Referral Center for Neuromuscular Diseases 'AOC', University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; ALS Center, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Solé G; Department of Neurology, Muscle-Nerve Unit, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; Referral Center for Neuromuscular Diseases 'AOC', University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Damon-Perrière N; Department of Clinical Neurophysiology, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; Department of Movement disorders, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Rouanet-Larrivière M; Department of Clinical Neurophysiology, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Duval F; Department of Neurology, Muscle-Nerve Unit, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; Referral Center for Neuromuscular Diseases 'AOC', University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Prigent J; Department of Neurology, Muscle-Nerve Unit, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Nadal L; Department of Neurology, Muscle-Nerve Unit, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France., Péréon Y; CHU Nantes, Reference Centre for Neuromuscular Diseases AOC, Filnemus, Nantes, France., Le Masson G; Department of Neurology, Muscle-Nerve Unit, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; Referral Center for Neuromuscular Diseases 'AOC', University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.; ALS Center, University Hospitals of Bordeaux (CHU Bordeaux - Pellegrin Hospital), University of Bordeaux, Bordeaux, France.

Publikováno v: The neurologist [Neurologist] 2024 Jan 01; Vol. 29 (1), pp. 59-69. Date of Electronic Publication: 2024 Jan 01.

Functional and targeted proteomics characterization of a human primary endothelial cell model of the blood-brain barrier (BBB) for drug permeability studies.

Autor: Gomez-Zepeda D; Université Paris Cité, UMR-S 1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France; German Cancer Research Center (DKFZ), Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz), Immunoproteomics unit (D191), Mainz, Germany. Electronic address: davidgz.science@gmail.com., Perrière N; BrainPlotting SAS, Institut du Cerveau et de la Moelle épinière, Paris, France., Glacial F; BrainPlotting SAS, Institut du Cerveau et de la Moelle épinière, Paris, France., Taghi M; Université Paris Cité, UMR-S 1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France., Chhuon C; Université de Paris, Structure Fédérative de Recherche Necker, Proteomics Platform Necker, INSERM US24/CNRS UMS3633, Paris, France., Scherrmann JM; Université Paris Cité, UMR-S 1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France., Sergent P; Technologie Servier, Département de recherche biopharmaceutique, Orléans, France., Moreau A; Technologie Servier, Département de recherche biopharmaceutique, Orléans, France., Denizot C; Technologie Servier, Département de recherche biopharmaceutique, Orléans, France., Parmentier Y; Technologie Servier, Département de recherche biopharmaceutique, Orléans, France., Cisternino S; Université Paris Cité, UMR-S 1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Universitaire Necker-Enfants Malades, Service Pharmacie, Paris, France., Decleves X; Université Paris Cité, UMR-S 1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, UF Biologie du médicament et toxicologie, Paris, France., Menet MC; Université Paris Cité, UMR-S 1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Paris, France; Institut de Chimie Physique, CNRS 8000, Université Paris-Saclay, 91405 Orsay, France. Electronic address: marie-claude.menet@universite-paris-saclay.fr.

Publikováno v: Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2023 Apr 15; Vol. 465, pp. 116456. Date of Electronic Publication: 2023 Mar 12.

Omega-3 fatty acids and brain energy metabolism: Impact on the expression of glucose transporters and glucose transport activity in endothelial cells in culture

Autor: Pifferi F., Jouin M., Roux F., Perrière N., Alessandri J-M., Lavialle M., Guesnet P.

Publikováno v: Oléagineux, Corps gras, Lipides, Vol 14, Iss 3-4, Pp 235-235 (2007)

Externí odkaz: https://doaj.org/article/1ca4dc7c5ce84d2e83a8f10579356a59

Prediction of Clinical Deep Brain Stimulation Target for Essential Tremor From 1.5 Tesla MRI Anatomical Landmarks.

Autor: Engelhardt J; Department of Neurosurgery, University Hospital of Bordeaux, Bordeaux, France.; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France., Cuny E; Department of Neurosurgery, University Hospital of Bordeaux, Bordeaux, France.; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France., Guehl D; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France.; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France., Burbaud P; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France.; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France., Damon-Perrière N; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France.; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France., Dallies-Labourdette C; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France.; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France., Thomas J; Institute for Neurodegenerative Disorders, CNRS-University of Bordeaux, Bordeaux, France.; Department of Neurology, University Hospital of Bordeaux, Bordeaux, France., Branchard O; Department of Neurosurgery, University Hospital of Bordeaux, Bordeaux, France., Schmitt LA; INRIA Bordeaux Sud-Ouest Research Centre, Talence, France., Gassa N; INRIA Bordeaux Sud-Ouest Research Centre, Talence, France., Zemzemi N; INRIA Bordeaux Sud-Ouest Research Centre, Talence, France.; Mathematical Institute of Bordeaux, University of Bordeaux, Bordeaux, France.

Publikováno v: Frontiers in neurology [Front Neurol] 2021 Oct 27; Vol. 12, pp. 620360. Date of Electronic Publication: 2021 Oct 27 (Print Publication: 2021).